Can I read HD21 Complete Primary Endpoint HD21 July 2023 on EtoBox?
HD21 Complete Primary Endpoint HD21 July 2023 by Karim Zriba is a document available to read on EtoBox.
What is HD21 Complete Primary Endpoint HD21 July 2023 about?
The GHSG HD21 trial compares the efficacy and treatment-related morbidity of PET2-guided BrECADD versus eBEACOPP in patients aged 18-60 with advanced stage classical Hodgkin Lymphoma. Interim results show a significant reduction in treatment-related morbidity with BrECADD while establishing non-inferiority in efficacy, with a 3-year progression-free survival rate of 94.9%. The trial sets a new standard of care for individualized treatment in this patient population.
- Author
- Karim Zriba
- Language
- EN